Peter Conlin, an attorney who has worked in state government and the insurance industry, has been named deputy insurance commissioner for policy and regulations and counsel to Insurance Commissioner Steve Poizner.

Dendreon Corp. has named to veterans of the biotech industry to its board of directors: Ian Clark, head of global product strategy and chief marketing officer at Roche, Pharma and Pedro Granadillo, retired senior vice president of global manufacturing and human resources at Eli Lilly & Co. (DNDN)

Drug maker Depomed Inc.’s stock price fell by more than a third after the company reported poor results from tests of a hot-flash drug. (DEPO)

Only three cities in the U.S. have better health-insurance coverage than Seattle, according to new U.S. Census Bureau data.

RehabCare Group Inc.’s proposed stock sale signals that it is preparing to buy a long-term acute care hospital or specialty hospital operator, an analyst said Monday. (RHB)